TABLE 3

Adherence to Guidelines Metrics by Study Group During the Baseline Period (Months 1–12)

Adherence to Guidelines MetricsTotal SampleStudy Group
CDS and FeedbackCDS OnlyFeedback OnlyCDS and Feedback
All OM
% adhering to guideline-recommended care (no. qualifying visits)
Pain assessed9694989598
(52 429)(17 568)(14 164)(12 117)(8580)
Pain treated3233273435
(8800)(2582)(2419)(1795)(2004)
AOM
% adhering to guideline-recommended care (no. qualifying visits)
AOM diagnostic evaluation4539464849
(37 103)(11 647)(10 480)(8647)(6329)
Amoxicillin as first-line therapy for AOM7168777064
(26 696)(7852)(7775)(6579)(4490)
High-dose amoxicillin for AOM4965423063
(18 984)(5387)(6038)(4634)(2925)
AOM treatment of penicillin-allergic patients7980757882
(1873)(612)(433)(445)(383)
AOM watchful waiting66746
(20 830)(6425)(6005)(5058)(3342)
OME
% adhering to guideline-recommended care (no. qualifying visits)
OME diagnostic evaluation737158
(7952)(3367)(1911)(1616)(1058)
OME watchful waiting8893877887
(2721)(1162)(698)(488)(373)
Avoidance of decongestants and antihistamines for OME98989998100
(465)(134)(135)(153)(43)
Summary measures for adherence to guidelines
Mean no. of adherence to guideline opportunities per visit3.02.93.13.03.0
Mean no. (%) adherence to guideline opportunities achieved per visit2.01.82.01.92.1
(66.7)(62.1)(64.5)(63.3)(70.0)
Comprehensive care: adherence to guideline opportunities achieved for visits with ≥3 opportunities, % (no. visits)
 AOM14.715.813.210.421.4
(30 063)(8962)(8575)(7300)(5226)
 OME4.92.35.39.06.6
(3331)(1400)(832)(600)(499)
 Either AOM or OME13.714.012.510.320.1
(33 394)(10 362)(9407)(7900)(5725)